Greetings. It's Wednesday, April 30th, 2025. Welcome to Denison Forum's Daily Article podcast. I'm Chris Elkins,

narrating today's daily article authored by our senior editor for Theology, Dr. Ryan Denison.

Mephrestone, one of two pills used in facilitating chemical abortions, gained FDA approval 25 years ago after a study of just under 31,000 participants showed that less than one-half of 1% experienced serious adverse reactions.

That statistic has since been cited to defend not only the use of the pill,

but also the removal of almost every safeguard that was put in place when it was first introduced to the

public. Initially, women could not obtain the drug until going to three in-person visits, after which

only a physician could prescribe and

dispense the pills, which had to be taken in the doctor's office. An in-office follow-up visit

was also required, and any adverse events that resulted from the pills had to be reported.

Now, none of what I just described is still the case. All that is required

today for a woman to receive the pills necessary to end a pregnancy is a tele-doc appointment

and a mailing address. So, perhaps it should not come as a surprise that Mephephastone is not nearly

as safe and effective as originally thought. And the reality is far worse than

you might imagine. A recent ethics and public policy center analysis of more than 865,000 cases

since 2017 has shown that, quote, 10.93% of women experience sepsis, infection, hemorrhaging, or another serious adverse event

within 45 days following a Mephepparstone abortion, end quote. That means serious complications

are 22 times more likely to occur than either the FDA or the pills makers have claimed.

The Ethics and Public Policy Center came to these conclusions by analyzing, quote,

real-world insurance claims data from 865,727 prescribed Mepheprestone abortions, broadly representative

of women who obtain Mepheprestone abortions in the of women who obtain Mephepristone abortions

in the U.S. today."

As such, where the initial study revolved around a closely monitored and selected group of women

...